Lactobacillus reuteri
AssigneePrecisionBiotics Group Limited
InventorJens WALTER
Life of this patent
Estimating the term…
Abstract
Lactobacillus reuteri strain having NCIMB accession number 42835 is from a novel phylogenetic clade and has unique immune-stimulatory properties and enhanced ecological performance in the human gut. A substrate for the strain, such as raffinose, may be administered at the same time as or separately from the strain.
Claims16
1-16. (canceled)
A formulation comprising a strain of Lactobacillus reuteri deposited under NCIMB accession number 42835 mixed with an excipient or carrier;
- wherein the excipient or carrier comprises a starch, a sugar, an alcohol, silicone, a wax, petroleum jelly, a vegetable oil, polyethylene glycol, propylene glycol, a liposome, gelatin, amylase, magnesium stearate, talc, a surfactant, silicic acid, viscous paraffin, perfume oil, a fatty acid monoglyceride, a fatty acid diglyceride, a petroethral fatty acid ester, hydroxymethyl-cellulose, or polyvinylpyrrolidone;
- and
- wherein the formulation is in the form of a tablet.
A method of treating a subject to increase gut microbiota diversity, the method comprising administering to the subject a formulation in the form of a tablet comprising Lactobacillus reuteri strain having NCIMB accession number 42835 mixed with an excipient or carrier, wherein the formulation increases the gut microbiota diversity in the subject.
Dependencies are inferred from the claim text.